行情

DBVT

DBVT

Dbv Technologies S A
NASDAQ

实时行情|Nasdaq Last Sale

1.531
+0.101
+7.06%
休市 16:00 05/27 EDT
开盘
1.480
昨收
1.430
最高
1.570
最低
1.480
成交量
2.70万
成交额
2.49万
52周最高
6.47
52周最低
1.150
市值
1.69亿
市盈率(TTM)
-1.9770
分时
5日
1月
3月
1年
5年
暂无数据
暂无数据
了解DBVT最新的财务预测,通过DBVT每股收益,每股净资产,每股现金流等数据分析Dbv Technologies S A近期的经营情况,然后做出明智的投资选择。
分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
66.67%买入
33.33%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测DBVT价格均价为7.03,最高价位10.05,最低价为5.02。
最高10.05
均价7.03
最低5.02
现价1.531
EPS
实际EPS
预期EPS
-0.51-0.42-0.34-0.25
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
机构持股
总机构数: 88
机构持股: 2,454.90万
持股比例: 22.28%
总股本: 1.10亿
类型机构数股数
增持
6
115.17万
建仓
9
20.31万
减持
7
611.04万
平仓
16
1,030.24万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
+0.69%
制药与医学研究
+1.28%
高管信息
Non-Executive Chairman/Independent Director
Michel De Rosen
Chief Executive Officer/Director
Daniel Tasse
Chief Financial Officer
Sebastien Robitaille
Other
Pharis Mohideen
Other
Michele Robertson
Non-Executive Director
Julie O'Neill
Non-Executive Independent Director
Mailys Ferrere
Non-Executive Independent Director
Michael Goller
Non-Executive Independent Director
Viviane Monges
Non-Executive Independent Director
Timothy Morris
Non-Executive Independent Director
Adora Ndu
Non-Executive Independent Director
Ravi Rao
Non-Executive Independent Director
Daniel Soland
暂无数据
暂无数据
DBVT 简况
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

微牛提供DBV Technologies SA(NASDAQ-DBVT)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的DBVT股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易DBVT股票基本功能。